Li et al. and Shantha Kumara et al. showed expression of MAGEA3 in 27.3% and 28% of CRC patients, respectively [19, 20], and MAGEA3 was also detected in 13% of CRC samples by Alves et al. [27] and postulated to elicit an immunological response. The gene discussed is MAGEA3; the disease is colorectal carcinoma.